Chengyao Chiang
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
18
Citations
307
Est. group size
~5
Recurring co-author estimate
Active years
11
Publishing since 2015
Chengyao Chiang's research focuses on the molecular biology of cancer, examining how proteins are chemically modified (such as through methylation) and how small molecules or drugs can target cancer cells to stop their growth or trigger their death. Work spans topics like epigenetic regulation (chemical modifications that control gene activity without changing DNA sequence), natural compounds as potential cancer drugs, and specific cancer types including lung, breast, cervical, and kidney cancers. This research combines molecular and cellular biology techniques with drug discovery approaches aimed at understanding cancer mechanisms and identifying new therapeutic targets.
Publication output was minimal before 2020, increased to a peak of 6 papers in 2022, and has since slowed to 1-2 papers per year through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Laxiflorin B covalently binds the tubulin colchicine-binding site to inhibit triple negative breast cancer proliferation and induce apoptosis
Chemico-Biological Interactions · 2023
- The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer
Frontiers in Genetics · 2022
- A Proximity-Triggered Strategy toward Transferable Proteolysis Targeting Chimeras
CCS Chemistry · 2022
- Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway
Toxicology Research · 2022
- YT521-B homology domain family proteins as N6-methyladenosine readers in tumors
Frontiers in Genetics · 2022
- A Novel Selective ERK1/2 Inhibitor, Laxiflorin B, Targets EGFR Mutation Subtypes in Non-small-cell Lung Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- A Novel Selective ERK1/2 Inhibitor, Laxiflorin B, Targets EGFR Mutation Subtypes in Non-Small-Cell Lung Cancer
SSRN Electronic Journal · 2022
- The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review
International Journal of Biological Sciences · 2021
- The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features
Translational Oncology · 2021
- Methylation of KRAS at lysine 182 and 184 by SETD7 promotes KRAS degradation
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Methylation of KRAS at Lysine 182 and 184 by SETD7 Promotes KRAS Degradation in Non-Small Cell Lung Cancer
SSRN Electronic Journal · 2021
- Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma
Theranostics · 2020
- Tacrolimus and ascomycin inhibit melanoma cell growth, migration and invasion via targeting nuclear factor of activated T-cell 3
Melanoma Research · 2020
- RXXPEG motif of MERIT40 is required to maintain spindle structure and function through its interaction with Tankyrase1
Cell Biology International · 2018
- Frontiers in Genetics×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- SSRN Electronic Journal×2
- Neuro-Oncology×2
- International Journal of Biological Sciences×1
- Ying Meng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Yasaman Heidarian
Biochemistry, Genetics and Molecular Biology · Indiana University
- Hongde Li
Biochemistry, Genetics and Molecular Biology · Indiana University
- Yanlin Jiang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Mircea Ivan
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile